KARYOPHARM THERAPEUTICS
Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation. Karyopharm Therapeutics is developing small molecule drugs that will modulate the activity of critical pathways in cancer, inflammation, and cell proliferation (e.g. FOXO, NFкB, P53, pRB) by targeting the nuclear pore complex machinery, which controls the import and export of proteins between the nucleus and cytoplasm. To successfully control transport through the nuclear pore complex, the company will use its unique technology platform, developed by Sharon Shacham, to identify novel small molecules, optimize them into clinical candidates, and to evaluate them in subsequent human clinical studies.
KARYOPHARM THERAPEUTICS
Industry:
Health Care Medical Pharmaceutical
Founded:
2008-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.karyopharm.com
Total Employee:
251+
Status:
Active
Contact:
+1 617 658 0600
Total Funding:
381.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Mobile Non Scaleable Content
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Board_member
2013-04-01
Board_member
2010-10-01
Advisor
Advisor
Advisor
Advisor
Advisor
Board_member
Current Employees Featured
Sharon Shacham Founder , CSO & President @ Karyopharm Therapeutics
Founder , CSO & President
2009-06-01
Brian Austad SVP, Pharmaceutical Sciences @ Karyopharm Therapeutics
SVP, Pharmaceutical Sciences
2018-02-01
Ronald A. DePinho Co-Founder @ Karyopharm Therapeutics
Co-Founder
Sohanya Cheng SVP Sales & Chief Commercial Officer @ Karyopharm Therapeutics
SVP Sales & Chief Commercial Officer
2021-06-01
Michael Kauffman CEO @ Karyopharm Therapeutics
CEO
2011-11-01
John McCartney Senior Director, Product Leadership @ Karyopharm Therapeutics
Senior Director, Product Leadership
Dilara McCauley Vice President, Product Leadership @ Karyopharm Therapeutics
Vice President, Product Leadership
Wen Chen Senior Director of Pharmaceutical Sciences, Formulation Development @ Karyopharm Therapeutics
Senior Director of Pharmaceutical Sciences, Formulation Development
Founder
Stock Details
Investors List
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Karyopharm Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Karyopharm Therapeutics
Delphi Ventures
Delphi Ventures investment in Series B - Karyopharm Therapeutics
Delphi Ventures
Delphi Ventures investment in Series B - Karyopharm Therapeutics
Chione
Chione investment in Series A - Karyopharm Therapeutics
Multiple Myeloma Research Foundation
Multiple Myeloma Research Foundation investment in Grant - Karyopharm Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-10 | Karyopharm Promotes Sohanya Cheng to Chief Commercial Officer |
Official Site Inspections
http://www.karyopharm.com Semrush global rank: 2.07 M Semrush visits lastest month: 10.09 K
- Host name: 156.218.184.35.bc.googleusercontent.com
- IP address: 35.184.218.156
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
